Administration of Lapatinib with Food Increases Its Plasma Concentration in Chinese Patients with Metastatic Breast Cancer: A Prospective Phase II Study

LESSONS LEARNED: Administration of lapatinib with food significantly increased its plasma concentration in Chinese patients with metastatic breast cancer. There were no serious adverse events during the study and no significant differences in lapatinib‐related adverse events between the fasted and f...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Fei, Lee, Kaping, Xia, Wen, Liao, Hai, Lu, Qianyi, Zhang, Jingmin, Yuan, Huimin, Zhang, Kai, Zheng, Qiufan, Qin, Ge, Zhai, Qinglian, Hong, Ruoxi, Jiang, Kuikui, Li, Yuan, Wang, Shusen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Clinical Trial Results
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485350/
https://www.ncbi.nlm.nih.gov/pubmed/32058619
http://dx.doi.org/10.1634/theoncologist.2020-0044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485350/
https://www.ncbi.nlm.nih.gov/pubmed/32058619
http://dx.doi.org/10.1634/theoncologist.2020-0044

Ejemplares similares